|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/127 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 38/47 | (2006.01) | ||
| A61K 47/24 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 2907504 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15158288.9 |
| Date of filing the European patent application | 2012-02-08 | |
| (97) | Date of publication of the European application | 2015-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-28 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161462875 P | 2011-02-08 | US |
| (72) |
Xiaoming, Li, US
Ramprasad, Mysore, US
Thompson, Curtis, US
Shepard, Harold Michael, US
Bookbinder, Louis Howard, US
Frost, Gregory Ian, US
|
| (73) |
Halozyme, Inc.,
11388 Sorrento Valley Road, San Diego, CA 92121,
US
|
| (54) | Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |
| Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia |